Dual EGFR blockade with cetuximab and erlotinib combined with anti-VEGF antibody bevacizumab in advanced solid tumors: a phase 1 dose escalation triplet combination trial. - Subbiah, Vivek; Dumbrava, Ecaterina Ileana; Jiang, Yunfang; Thein, Kyaw Z.; Naing, Aung; Hong, David S.; Fu, Siqing; Piha-Paul, Sarina A.; Tsimberidou, Apostolia M.; Janku, Filip; Meric-Bernstam, Funda; Kurzrock, Razelle; et al. (Experimental Hematology & Oncology, 2020)